Picture of Airsculpt Technologies logo

AIRS — Airsculpt Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

AirSculpt misses Q3 revenue estimates, cuts outlook

AirSculpt misses Q3 revenue estimates, cuts outlook


Overview

  • US body contouring procedures provider's Q3 revenue fell 8.7%, missing analysts' expectations

  • Adjusted loss per share was larger than expected, while adjusted EBITDA missed estimates

  • Company cut 2026 revenue and adjusted EBITDA guidance after Q3 underperformance


Outlook

  • AirSculpt cuts 2026 revenue outlook to $144 mln-$146 mln from $151 mln-$157 mln

  • Company lowers 2026 adjusted EBITDA guidance to $9 mln-$10 mln from $12 mln-$14 mln

  • Company expects third quarter performance trends to continue through year-end


Result Drivers

  • CASE VOLUME DECLINE - Co said lower case volume contributed to revenue decline

  • GLP-1 PROCEDURES - Co said expansion of GLP-1-related procedures represented about 10% of total cases in Q3


Company press release: ID:nGNX636JYd


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$31.94 mln

$34.44 mln (4 Analysts)

Q3 Adjusted Loss Per Share

Miss

$0.08

$0.05 (4 Analysts)

Q3 Net Loss

$7.2 mln

Q3 Adjusted EBITDA

Miss

$400,000

$1.67 mln (3 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for AirSculpt Technologies Inc is $3.00, about 108.3% above its November 5 closing price of $1.44


Reuters Recommended Reads

  • Nov 4 - Evolus Q3 revenue rises 13% on toxin and HA gel growth

  • Nov 6 - Lilly to sell obesity drugs directly on Hims & Hers site

  • Nov 3 - Rhythm Pharma Q3 net loss narrower than estimated on IMCIVREE demand


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Airsculpt Technologies

See all news